Effect of myocardial revascularization upon long-term prognosis of patients with acute coronary syndrome and concomitant diseases

R.R. Komorovsky

References    

1. Barch RG, Cannon CP, Weintraub WS. et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndrome. Ann Intern Med.2004;141(3):186-195.
2. Barnett K, Mercer SW, Norbury M. et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet.2012;380 (9836):37-43. doi: 10.1016/S0140-6736(12)60240-2.
3. Braunwald E, Antman EM, Beasley JW. et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2000;36:970-1062. doi: 10.1016/S0735-1097(00)00889-5.
4. Douglas PS, Garcia MJ, Haines DE, et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 appropriate use criteria for echocardiography. J Am Coll Cardiol. 2011;57:1126-1166. doi: 10.1016/j.jacc.2010.11.002.
5. Ibanez B, James S, Agewall S. et al for the ESC Scientific Document Group. 2017 Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119-177. doi: 10.1093/eurheartj/ehx393.
6. Januzzi JLJr, Buros J, Cannon CP. Peripheral arterial disease, acute coronary syndromes, and early invasive management: the TACTICS TIMI 18 trial. Clin Cardiol.2005;28(5):238-242. doi: 10.1002/clc.4960280508.
7. Januzzi JL, Cannon CP, DiBattiste PM. et al. for the TACTICS-TIMI Investigators. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS TIMI 18 trial). Am J Cardiol.2002;90(11):1246-1249. doi: 10.1016/S0002-914(02)02844-8.
8. Komorovsky R, Coscarelli S, Desideri A. et al. Extracoronary artery disease as a risk factor for coronary events after revascularization in patients with acute coronary syndromes. J. Coronary Artery Dis.2003;5:54.
9. Komorovsky R, Desideri A, Coscarelli S. et al. Impact of carotid arterial narrowing on outcomes of patients with acute coronary syndromes. Am J Cardiol. 2004;93:1552-1555. doi: 10.1016/j.amjcard.2004.03.012.
10. Negers A, Boddaert J, Mora L. et al. Determinants of invasive strategy in elederly patients with non-ST elevation myocardial infarction. J Geriatr Cardiol. 2017;14(7):465-472. doi: 10.11909/j.issn.1671-5411.2017.07.001.
11. Neumann FJ, Sousa-Uva M, Ahlsson A. et al. 2018 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2019;40:87-165. doi: 10.1093/eurheartj/ehy394.
12. Palau P, Núñez J, Sanchis J. et al. Differential prognostic effect of revascularization according to a simple comorbidity index in high-risk non-ST-segment elevation acute coronary syndrome. Clin Cardiol. 2012;35:237-243. doi: 10.1002/clc.20996.
13. Radovanovic D, Seifert B, Urban P. et al, on behalf of the AMIS Plus Investigators. Validity of Charlson comorbidity index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012. Heart. 2014;100:288-294. doi: 10.1136/heartjnl-2013-304588.
14. Roffi M, Patrono C, Collet JP. et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267-315. doi: 10.1093/eurheartj/ehv320.
15. Sanchis J, Núñez E, Barrabés JA. et al. Randomized comparison between the invasive and conservative strategies in comorbid elderly patients with non-ST elevation myocardial infarction. Eur J Intern Med. 2016;35:89-94. doi: 10.1016/j.ejim.2016.07.003.
16. Sanchis J, Núñez J, Bodí V. et al. Influence of comorbid conditions on one-year outcomes in non-ST-segment elevation acute coronary syndrome. Mayo Clin Proc. 2011;86:291-296. doi: 10.4065/mcp.2010.0702.
17. Schellevis FG, Velden JVD, Lisdonk EVD. et al. Comorbidity of chronic diseases in general practice. J Clin Epidemiol. 1993;46:469-473. doi: 10.1016/0895-4356(93)90024-U.
18. Steg PG, Kerner A, Van de Werf F. et al. for Global Registry of Acute Coronary Events (GRACE) invastigators. Impact of in-hospital revascularization on survival in patients with non-ST-elevation acute coronary syndrome and congestive heart failure. Circulation. 2008;118(11):1163-1171. doi: 10.1161/circulationaha.108.789685.
19. Valgimigli M, Bueno H, Byrne R.A. et al. 2017 ESC Focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: Task Force for of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39:213-260. doi: 10.1093/eurheartj/ehx419.